Share of clinical development medicines dedicated to non-communicable diseases

STO-REC-STAT01M2KJT2 National
75%

Global · 2025

Share of clinical development medicines dedicated to non-communicable diseases worldwide stood at 75% in 2025 (IFPMA).

Original source
Publisher
IFPMA
Authority tier
T2 National
Locator
Enabling innovation: The R&D ecosystem for medicines and vaccines
Retrieved
15 Sep 2026
Status
Verified

What the source says

And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).

Verbatim extraction verified: The figure 75% is directly attested in the quoted passage (Enabling innovation: The R&D ecosystem for medicines and vaccines).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1
MLA
IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025, https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1.
Chicago
IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025. https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1.
BibTeX
@misc{ifpma2025sharebjmgf1, author = {{IFPMA}}, title = {Enabling innovation: The R\&D ecosystem for medicines and vaccines}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1}, note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT01M2KJ T2 National

Primary Source

Publisher
IFPMA · homepage ↗
Authority tier
Tier 2 · National Official
Report
Enabling innovation: The R&D ecosystem for medicines and vaccines
Type
Press release
Published
Locator
Enabling innovation: The R&D ecosystem for medicines and vaccines
Retrieved
15 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
15 September 2026
Last revision
15 September 2026
Archival URI
/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1